YIRMANA

Serial Number 86587271
606

Registration Progress

Application Filed
Apr 3, 2015
Under Examination
Mar 1, 2016
Approved for Publication
Jan 5, 2016
Published for Opposition
Jan 5, 2016
Registered

Trademark Image

YIRMANA

Basic Information

Serial Number
86587271
Filing Date
April 3, 2015
Published for Opposition
January 5, 2016
Abandonment Date
April 1, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 1, 2019
Classes
005 010

Rights Holder

Intarcia Therapeutics, Inc.

03
Address
One Marina Park Drive
Suite 1300
Boston, MA 02210

Ownership History

Intarcia Therapeutics, Inc.

Original Applicant
03
Boston, MA

Intarcia Therapeutics, Inc.

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Maury M. Tepper, III

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

41 events
Date Code Type Description Documents
Apr 1, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 1, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 5, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 5, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 26, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 25, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 25, 2018 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 18, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 18, 2018 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 2, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 28, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 28, 2018 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 28, 2018 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 18, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 16, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 16, 2017 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 16, 2017 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 2, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 2, 2017 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 2, 2017 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 31, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 31, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 31, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 26, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 24, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 24, 2016 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 24, 2016 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 1, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 5, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 5, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 16, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 19, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 18, 2015 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 18, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 18, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 18, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 18, 2015 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 18, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 15, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 14, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 7, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of diabetes, obesity, and metabolic diseases and disorders; drug delivery devices in the nature of an implantable pump filled with pharmaceutical preparations for the treatment of diabetes, obesity, and metabolic diseases and disorders; drug delivery system comprised of an implantable pump for use in release of therapeutic formulations for the treatment of diabetes, obesity, and metabolic diseases and disorders; therapeutic agents for the treatment of diabetes
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
Drug delivery system devices and systems, namely an implantable pump; implantable mini-pumps sold empty for release of therapeutic agents for medical uses
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 010